Frequently Asked Questions about Hologic, Inc. (HOLX)

Name: Hologic, Inc. (HOLX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Hologic, Inc. (HOLX) do?

Accepted Answer

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast...

Question 2

Is Hologic, Inc. (HOLX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of HOLX reveals an Altman Z-Score of 4.22 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($4.10B most recent), help investors decide if HOLX fits their risk profile.

Question 3

What is the current P/E ratio for HOLX?

Accepted Answer

As of the latest trading session, Hologic, Inc. (HOLX) has a trailing P/E ratio of 31.36.

Question 4

Who is the CEO of Hologic, Inc.?

Accepted Answer

The current Chief Executive Officer of Hologic, Inc. is Stephen MacMillan.

Question 5

What was HOLX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Hologic, Inc. reported annual revenues of $4.10B (2025), $4.03B (2024), $4.03B (2023), $4.86B (2022), $5.63B (2021) respectively.

Question 6

Does HOLX pay a dividend?

Accepted Answer

Hologic, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does HOLX have?

Accepted Answer

In its latest reporting period, Hologic, Inc. generated $0.92B in Free Cash Flow against a total debt load of $2.63B.

Question 8

What is the Price-to-Book (P/B) ratio of Hologic, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Hologic, Inc. (HOLX) is currently 3.25.

Question 9

What is the Price-to-Sales (P/S) ratio of HOLX?

Accepted Answer

Based on trailing twelve-month data, Hologic, Inc. (HOLX) trades at a Price-to-Sales (P/S) ratio of 4.11.

Question 10

What is Hologic, Inc.'s Return on Equity (ROE)?

Accepted Answer

Hologic, Inc. (HOLX) has a Return on Equity (ROE) of 11.01%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-09	4.1B	2.5B	714.3M	565.7M	2.50
2024-09	4B	2.2B	882.6M	789.5M	3.35
2023-09	4B	2.1B	668.4M	456M	1.85
2022-09	4.9B	3B	1.6B	1.3B	5.18
2021-09	5.6B	3.8B	2.5B	1.9B	7.28

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-09	4.1B	2.5B	714.3M	565.7M	2.50
2024-09	4B	2.2B	882.6M	789.5M	3.35
2023-09	4B	2.1B	668.4M	456M	1.85
2022-09	4.9B	3B	1.6B	1.3B	5.18
2021-09	5.6B	3.8B	2.5B	1.9B	7.28